Scroll Back to Top

臨床薬理関連サービス

The experience you need to make rapid “go/no-go” decisions

コーヴァンスとつながる

We inform decision-making and accelerate development by navigating the complexities of early phase studies, anticipating risks and opportunities and applying data-driven insights.

Built for success

250 名を超える Fortea のチームメンバーが初期フェーズ試験を専門に担当。

Deep experience

Our clinical pharmacology team brings over 30 years of direct drug development experience.

A vast site network

世界 300ヵ所以上の治験実施施設を活用して初期フェーズ試験を最適化。

Informed decisions for asset development

Fortrea provides the link between preclinical data and new treatments for patients. Our dedicated scientists and clinicians deliver comprehensive drug safety, tolerability, pharmacokinetic and pharmacodynamic data-and a complete in-house team to enable you to scrutinize development progress and deliver unique insights that inform critical decisions. As one of the largest early stage clinical research organizations in the world, we offer a comprehensive suite of pharmacology services to manage every step of your early clinical development.

The expertise to manage complexities

As we manage the conduct of your complex study, we never take our eyes off the two critical focal points-scientific integrity and human subject safety. Fortrea is built to manage the ever-growing complexity of product development with end-to-end patient safety solutions. Our integrated clinical study platform handles multisite hybrid study designs, rapid-sequence dose escalations, sophisticated biomarker or imaging exploratory endpoints, extemporaneous investigational product preparation and more.

Early phase experience that matters

In the past five years we have:

1,000+ Databases locked
90%+ Healthy volunteer and patient enrollment targets met
28K+ 患者様

A flexible model delivers the right support

お客様に必要なのは、ご自身の研究にとって最も重要なリソースへのアクセスです。必要以上に大規模なリソースに煩わされることはありません。そのことを踏まえて、当社では、お客様が最終目標を達成されるうえで必要となる戦略、実行、リソース、ツールを適切に組み合わせて提供しています。

We offer you a deep, experienced team focused on this crucial phase of molecule development and deliver results as you introduce your compound in humans and move to proof-of-concept.将来のフェーズを見据えた臨床への移行において、当社をぜひご活用ください。